09/10/21 |
NCI |
Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
05/07/24 |
NCI |
Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 08/21/24 |
04/29/22 |
NCI |
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
10/04/23 |
NCI |
Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk |
Link |
NIH NOSI |
Application due: 09/08/24 |
09/15/22 |
NCI |
Notice of Special Interest: Administrative Supplements to Participate in the NCI Early-stage Surgeon Scientist Program (ESSP) |
Link |
NOSI |
|
09/18/20 |
NCI |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 - Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
01/17/24 |
NCI |
Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention |
Link |
NIH NOSI |
Application due: 05/08/29 |
05/07/24 |
NCI |
Notice of Special Interest (NOSI): Research Council of Finland (RCF) – National Institutes of Health (NIH) Partnership Program |
Link |
NIH NOSI |
Application due: 01/08/25 |
09/24/20 |
NCI |
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
12/20/23 |
NCI |
Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications |
Link |
NIH NOSI |
Application due: 01/27/27 |
07/08/22 |
NCI |
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors |
Link |
NIH NOSI |
Application due: 10/09/24 |
07/22/22 |
NCI |
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/11/24 |
08/11/23 |
NCI |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
09/18/20 |
NCI |
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
12/13/23 |
NCI |
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) |
Link |
Foundation |
Application due: 06/14/24 |
06/17/22 |
NCI |
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 11/17/24 |
09/15/22 |
NCI |
Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) |
Link |
NIH |
Application due: 07/01/24 |
03/31/24 |
NCI |
Notice of Special Interest (NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being |
Link |
NIH NOSI |
Application due: 11/14/27 |
09/15/22 |
NCI |
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 06/20/24 |
08/11/23 |
NCI |
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
12/13/23 |
NCI |
Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
Link |
NIH NOSI |
Application due: 05/01/25 |
08/02/22 |
NCI |
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/07/24 |
04/01/22 |
NCI |
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/11/23 |
NCI |
Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials |
Link |
NIH NOSI |
Application due: 07/01/25 |
12/13/23 |
NCI |
Assessment of Climate at Institutions (ACt) Award (RC2 - Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 07/01/24 |
07/22/22 |
NCI |
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
07/22/22 |
NCI |
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/11/24 |
03/11/24 |
NCI |
Notice of Special Interest (NOSI): Telehealth Research in Cancer Care |
Link |
NIH NOSI |
Application due: 03/17/26 |
07/22/22 |
NCI |
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/12/24 |
05/07/24 |
NCI |
Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity |
Link |
NIH NOSI |
Application due: 11/29/24 |
08/02/22 |
NCI |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
03/11/24 |
NCI |
Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk |
Link |
NIH NOSI |
Application due: 05/09/26 |
06/17/22 |
NCI |
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
05/07/24 |
NCI |
Notice of Special Interest (NOSI): Administrative Supplements for NCI Center for Global Health Research Programs |
Link |
NIH NOSI |
Application due: 05/23/24 |
12/20/22 |
NCI |
National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
06/05/23 |
NCI |
Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities |
Link |
NIH NOSI |
Application due: 10/10/26 |
07/22/22 |
NCI |
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
10/14/22 |
NCI |
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
01/17/24 |
NCI |
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers |
Link |
NIH NOSI |
Application due: 07/02/25 |
05/07/24 |
NCI |
Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research |
Link |
NIH NOSI |
Application due: 06/14/24 |
10/21/22 |
NCI |
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, 2023 (P50 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
08/06/21 |
NCI |
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
05/07/24 |
NCI |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
04/10/23 |
NCI |
Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
12/11/20 |
NCI |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/29/23 |
NCI |
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/15/22 |
NCI |
Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment |
Link |
NIH NOSI |
Application due: 10/09/24 |
03/31/24 |
NCI |
Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention |
Link |
NIH NOSI |
Application due: 05/08/29 |
08/11/23 |
NCI |
Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings |
Link |
NIH NOSI |
Application due: 11/18/25 |
08/02/22 |
NCI |
Biology of Bladder Cancer (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
10/21/22 |
NCI |
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
07/27/23 |
NCI |
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
12/13/23 |
NCI |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/22/22 |
NCI |
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
10/30/23 |
NCI |
Notice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research |
Link |
NIH NOSI |
Application due: 07/31/27 |
08/02/22 |
NCI |
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 06/11/24 |
05/07/24 |
NCI |
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) |
Link |
NIH |
Standard due dates apply |
04/02/21 |
NCI |
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 06/18/24 |
09/10/21 |
NCI |
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
01/17/24 |
NCI |
Notice of Special Interest (NOSI): Chronic Inflammation of the Oral Cavity - An Agent for Oral Mucosal Disease |
Link |
NIH NOSI |
Application due: 05/10/27 |
02/04/22 |
NCI |
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
05/07/24 |
NCI |
Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required) |
Link |
NIH |
Standard due dates apply |
12/05/22 |
NCI |
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 10/23/24 |
10/04/23 |
NCI |
Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
05/07/24 |
NCI |
NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional) |
Link |
NIH |
Application due: 09/06/24 |
04/10/23 |
NCI |
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
09/18/20 |
NCI |
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 No Independent Clinical Trials) |
Link |
NIH |
Standard due dates apply |
12/13/23 |
NCI |
Notice of Intent to Publish a Notice of Funding Opportunity for National Cancer Institute's Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (U54 Clinical Trial Optional) |
Link |
NIH NOSI |
Application due: 09/25/24 |
07/22/22 |
NCI |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
12/13/23 |
NCI |
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) |
Link |
NIH |
Application due: 06/14/24 |
04/17/20 |
National Science Foundation |
NSF Rapid Response Research (RAPID) - various opps |
Link |
NSF COVID-19 |
|
01/30/22 |
METAvivor |
METAvivor Research Grants (various) |
Link |
Foundation |
LOI due date varies by grant |
10/21/22 |
Mesothelioma Applied Research Foundation |
2022 Mesothelioma Research Grant |
Link |
Foundation |
LOI due: 11/21/2022 |
05/07/24 |
Memorial Sloan Kettering Cancer Center |
Bone and Soft Tissue Pathology Fellowship |
Link |
Fellowship |
Application due: 11/30/24 |
08/29/23 |
Memorial Sloan Kettering Cancer Center |
Clinical Chemistry Fellowship |
Link |
Foundation |
|
09/23/22 |
Melanoma Research Foundation (MRF) |
Melanoma Research Foundation Research Grant RFPs (various) |
Link |
Foundation |
Due date varies by grant |
01/22/24 |
Melanoma Research Foundation |
Melanoma Research Foundation RFP (various) |
Link |
Foundation |
Due dates vary by grant |
08/11/23 |
Melanoma Research Alliance |
Melanoma Research Alliance RFP |
Link |
Foundation |
LOI due: 09/20/2023 |
05/07/24 |
Maryland Department of Health |
MHHD Grant Programs |
Link |
MDH |
|